Skip to main content
Have a personal or library account? Click to login
Fluorescence imaging agents in cancerology Cover

Fluorescence imaging agents in cancerology

Radiology and Oncology
Volume 44 (2010): Issue 3 (September 2010)
By: ,  ,  ,  ,   and    
Open Access
|Jun 2010
References

References

  1. Sodee DB, Conant R, Chalfant M, Miron S, Klein E, Bahnson R, et al. Preliminary imaging results using In-111 labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancer.1996;: 759-67.
    Open DOISearch in Google Scholar
  2. Nanus DM, Milowsky MI, Kostakoglu L, Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, et al. Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen.2003;(6 Pt 2): S84-8; discussion S88-9.
    Open DOISearch in Google Scholar
  3. Abdel-Nabi H, Doerr RJ, Chan HW, Balu D, Schmelter RF, Maguire RT. In-111-labeled monoclonal antibody immunoscintigraphy in colorectal carcinoma: safety, sensitivity, and preliminary clinical results.1990;: 163-71.
    Open DOISearch in Google Scholar
  4. Moffat FL, Jr., Pinsky CM, Hammershaimb L, Petrelli NJ, Patt YZ, Whaley FS, et al. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.1996;: 2295-305.
    Open DOISearch in Google Scholar
  5. Breitz HB, Tyler A, Bjorn MJ, Lesley T, Weiden PL. Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy.1997;: 615-20.
    Open DOISearch in Google Scholar
  6. Weissleder R. A clearer vision for in vivo imaging.2001;: 316-7.
    Open DOISearch in Google Scholar
  7. Wagnieres GA, Star WM, Wilson BC. In vivo fluorescence spectroscopy and imaging for oncological applications.1998;: 603-32.
    Open DOISearch in Google Scholar
  8. Rajwa B, Bernas T, Acker H, Dobrucki J, Robinson JP. Single- and two-photon spectral imaging of intrinsic fluorescence of transformed human hepatocytes.2007;: 869-79.
    Open DOISearch in Google Scholar
  9. Troy T, Jekic-McMullen D, Sambucetti L, Rice B. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models.2004;: 9-23.
    Open DOISearch in Google Scholar
  10. Inoue Y, Izawa K, Kiryu S, Tojo A, Ohtomo K. Diet and abdominal autofluorescence detected by in vivo fluorescence imaging of living mice.2008;: 21-7.
    Open DOISearch in Google Scholar
  11. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets.2003;: 123-8.
    Open DOISearch in Google Scholar
  12. Chang K, Jaffer F. Advances in fluorescence imaging of the cardiovascular system.2008;: 417-28.
    Open DOISearch in Google Scholar
  13. Ballou B. Quantum dot surfaces for use in vivo and in vitro.2005;: 103-20.
    Open DOISearch in Google Scholar
  14. Rao J, Dragulescu-Andrasi A, Yao H. Fluorescence imaging in vivo: recent advances.2007;: 17-25.
    Open DOISearch in Google Scholar
  15. Jin ZH, Josserand V, Razkin J, Garanger E, Boturyn D, Favrot MC, et al. Noninvasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4.2006;: 188-97.
    Open DOISearch in Google Scholar
  16. Thomas TP, Patri AK, Myc A, Myaing MT, Ye JY, Norris TB, et al. In vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles.2004;: 2269-74.
    Open DOISearch in Google Scholar
  17. Zhang T, Stilwell JL, Gerion D, Ding L, Elboudwarej O, Cooke PA, et al. Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements.2006;: 800-8.
    Open DOISearch in Google Scholar
  18. Stroh M, Zimmer JP, Duda DG, Levchenko TS, Cohen KS, Brown EB, et al. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo.2005;: 678-82.
    Open DOISearch in Google Scholar
  19. Lupold SE, Hicke BJ, Lin Y, Coffey DS. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.2002;: 4029-33.
    Search in Google Scholar
  20. Patri AK, Myc A, Beals J, Thomas TP, Bander NH, Baker JR, Jr. Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy.2004;: 1174-81.
    Open DOISearch in Google Scholar
  21. Lisy MR, Goermar A, Thomas C, Pauli J, Resch-Genger U, Kaiser WA, et al. In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice.2008;: 779-87.
    Open DOISearch in Google Scholar
  22. Chen CH, Chernis GA, Hoang VQ, Landgraf R. Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3.2003;: 9226-31.
    Open DOISearch in Google Scholar
  23. Shukla R, Thomas TP, Peters JL, Desai AM, Kukowska-Latallo J, Patri AK, et al. HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.2006;: 1109-15.
    Open DOISearch in Google Scholar
  24. Veiseh M, Gabikian P, Bahrami SB, Veiseh O, Zhang M, Hackman RC, et al. Tumor paint: a chlorotoxin: Cy5.5 bioconjugate for intraoperative visualization of cancer foci.2007;: 6882-8.
    Open DOISearch in Google Scholar
  25. Shukla R, Thomas TP, Peters J, Kotlyar A, Myc A, Baker Jr JR. Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates.2005;: 5739-41.
    Open DOISearch in Google Scholar
  26. Cai W, Chen X. Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging.2008;: 89-96.
    Open DOISearch in Google Scholar
  27. Gunn AJ, Hama Y, Koyama Y, Kohn EC, Choyke PL, Kobayashi H. Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore.2007;: 1727-33.
    Open DOISearch in Google Scholar
  28. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots.2004;: 969-76.
    Open DOISearch in Google Scholar
  29. Kaushal S, McElroy MK, Luiken GA, Talamini MA, Moossa AR, Hoffman RM, et al. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer.2008;: 1938-50.
    Open DOISearch in Google Scholar
  30. Virostko J, Xie J, Hallahan DE, Arteaga CL, Gore JC, Manning HC. A molecular imaging paradigm to rapidly profile response to angiogenesis-directed therapy in small animals.2009;: 204-12.
    Open DOISearch in Google Scholar
  31. Takeda M, Tada H, Higuchi H, Kobayashi Y, Kobayashi M, Sakurai Y, et al. In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine.2008;: 145-52.
    Open DOISearch in Google Scholar
  32. Kamaly N, Kalber T, Thanou M, Bell JD, Miller AD. Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging.2009;: 648-55.
    Open DOISearch in Google Scholar
  33. Yang C, Ding N, Xu Y, Qu X, Zhang J, Zhao C, et al. Folate receptor-targeted quantum dot liposomes as fluorescence probes.2009;: 502-11.
    Open DOISearch in Google Scholar
  34. Ferreira CS, Matthews CS, Missailidis S. DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers.2006;: 289-301.
    Open DOISearch in Google Scholar
  35. Perkins AC, Missailidis S. Radiolabelled aptamers for tumour imaging and therapy.2007;: 292-6.
    Search in Google Scholar
  36. Charlton J, Sennello J, Smith D. In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase.1997;: 809-16.
    Open DOISearch in Google Scholar
  37. Hicke BJ, Stephens AW, Gould T, Chang YF, Lynott CK, Heil J, et al. Tumor targeting by an aptamer.2006;: 668-78.
    Search in Google Scholar
  38. Pieve CD, Perkins AC, Missailidis S. Anti-MUC1 aptamers: radiolabelling with (99m)Tc and biodistribution in MCF-7 tumour-bearing mice.2009;: 703-10.
    Open DOISearch in Google Scholar
  39. Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S, Kantoff PW, Langer R, et al. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer.2007;: 3065-70.
    Open DOISearch in Google Scholar
  40. Razkin J, Josserand V, Boturyn D, Jin ZH, Dumy P, Favrot M, et al. Activatable fluorescent probes for tumour-targeting imaging in live mice.2006;: 1069-72.
    Open DOISearch in Google Scholar
  41. Bremer C, Bredow S, Mahmood U, Weissleder R, Tung CH. Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model.2001;: 523-9.
    Open DOISearch in Google Scholar
  42. Reshetnyak YK, Andreev OA, Lehnert U, Engelman DM. Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix.2006;: 6460-5.
    Open DOISearch in Google Scholar
  43. Andreev OA, Dupuy AD, Segala M, Sandugu S, Serra DA, Chichester CO, et al. Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo.2007;: 7893-8.
    Open DOISearch in Google Scholar
  44. Jin ZH, Razkin J, Josserand V, Boturyn D, Grichine A, Texier I, et al. In vivo noninvasive optical imaging of receptor-mediated RGD internalization using self-quenched Cy5-labeled RAFT-c(-RGDfK-)(4).2007;: 43-55.
    Open DOISearch in Google Scholar
  45. Ballou B, Ernst LA, Waggoner AS. Fluorescence imaging of tumors in vivo.2005;: 795-805.
    Open DOISearch in Google Scholar
  46. Ntziachristos V, Bremer C, Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging.2003;: 195-208.
    Open DOISearch in Google Scholar
  47. Swanson SD, Kukowska-Latallo JF, Patri AK, Chen C, Ge S, Cao Z, et al. Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.2008;: 201-10.
    Search in Google Scholar
  48. Zhu W, Okollie B, Bhujwalla ZM, Artemov D. PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approach.2008;: 679-85.
    Open DOISearch in Google Scholar
  49. Thomas TP, Majoros IJ, Kotlyar A, Kukowska-Latallo JF, Bielinska A, Myc A, et al. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.2005;: 3729-35.
    Open DOISearch in Google Scholar
  50. Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.2000;: 133-48.
    Open DOISearch in Google Scholar
  51. Xu R, Wang Y, Wang X, Jeong EK, Parker DL, Lu ZR. In vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent.2007;: 1081-9.
    Open DOISearch in Google Scholar
  52. Hill E, Shukla R, Park SS, Baker JR, Jr. Synthetic PAMAM-RGD conjugates target and bind to odontoblast-like MDPC 23 cells and the predentin in tooth organ cultures.2007;: 1756-62.
    Open DOISearch in Google Scholar
  53. Boswell CA, Eck PK, Regino CA, Bernardo M, Wong KJ, Milenic DE, et al. Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers.2008;: 527-39.
    Open DOISearch in Google Scholar
  54. Majoros IJ, Williams CR, Baker JR, Jr. Current dendrimer applications in cancer diagnosis and therapy.2008;: 1165-79.
    Open DOISearch in Google Scholar
  55. Baker M. Whole-animal imaging: The whole picture.2010;: 977-80.
    Open DOISearch in Google Scholar
  56. Nguyen QT, Olson ES, Aguilera TA, Jiang T, Scadeng M, Ellies LG, et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival.2010;: 4317-22.
    Open DOISearch in Google Scholar
  57. Yildirim M, Engin O, Oztekin O, Akdamar F, Adibelli ZH. Diagnostic evaluation and surgical management of recurrent hydatid cysts in an endemic region.2009;:162-9.
    Open DOISearch in Google Scholar
  58. Avazpour I, Roslan RE, Bayat P, Saripan MI, Nordin AJ, Azmir RS et al. Segmenting CT images of bronchogenic carcinoma with bone metastases using PET intensity markers approach.2009;: 180-6.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-010-0031-y | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 142 - 148
Published on: Jun 16, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Photonic imaging,
fluorescence,
cancerology,
apramers,
smart probes
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2010 Aurélie Paganin-Gioanni, Elisabeth Bellard, Laurent Paquereau, Vincent Ecochard, Muriel Golzio, Justin Teissié, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 44 (2010): Issue 3 (September 2010)
Previous article
Next article